Health Condition 1: null- Cataract
Conditions
Interventions
Intervention1: Eyecryl ACTV Diffractive Multifocal IOL: Multifocal lens by Biotech Vision Care Pvt Ltd., India
Control Intervention1: AcrySof® IQ ReSTOR®: Multifocal IOL by Alcon A Novartis Divison
Sponsors
Biotech Vision Care Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Patients who has been implanted bilaterally with any one of the Multifocal IOL: Eyecryl ACTV Diffractive Multifocal IOL OR AcrySof® IQ ReSTOR® multifocal IOL will be included in the study. Age 18 and older Regular corneal topography and corneal astigmatism Preoperative & postoperative corneal astigmatism of Clear intraocular media Availability, willingness and sufficient cognitive awareness to comply with examination procedures Written informed consent for participation in the study and data protection
Exclusion criteria
Exclusion criteria: Patients with best corrected vision less than 6/9 and or N/6 Pupil Size: > 5 mm scotopic size Previous ocular surgery. Any active ocular disease (Diabetic retinopathy, macular degeneration, glaucoma with field defects and irregular corneal astigmatism) Any ocular pathology (corneal, retinal) Subject who are professional Pilots/truck/Car Drivers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Compare Visual acuity (Distance, Near and Intermediate vision), Contrast sensitivity(Low and High)Timepoint: Pre Operative 1 month 3 months 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| High Order aberrations Reading Speed Defocus Curve Steriopsis for depth of vsion Adverse Event/complication after implanting Study IOLs Improvement in Quality of Life Photic phenomena by dysphotopsia questionnaireTimepoint: Pre Operative 1 month 3 months 6 months | — |
Countries
India
Contacts
Public ContactDr Vijay Shetty
Laxmi Eye Institute and Charitable Trus
Outcome results
None listed